
ENCell’s EN001 Gets FDA Orphan Drug Designation for CMT Disease
ENCell’s EN001 Receives FDA Orphan Drug Designation for Charcot-Marie-Tooth Disease ENCell, a leading biopharmaceutical company specializing in cell and gene therapy, has announced that its investigational drug, EN001, has been granted Orphan Drug Designation (ODD) by the U.S. Food and…












